Difference between revisions of "Gliadoralin A"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 43: | Line 43: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:39, 10 March 2015
| Gliadoralin A | |
|---|---|
| Substrate peptide name | Gliadoralin A |
| Synonyms | |
| Determination type | In vitro |
| Source | Rattus rattus |
| Subcellular localization | Secreted |
| Swissprot ID | D3Z9M3 |
| Reactive glutamines | |
| Reactive lysines | K60 |
| Substrate sequence | |
| Structure | |
| Surface accessibility | |
| Disorder prediction | |
| Reference | PMID:23637100 |
| Notes | |
